Trade CUE stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Cue Biopharma, Inc. (CUE) is trading at US$37.05, down 2.09% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$174.2M. Over the past 52 weeks, CUE has traded between US$4.97 and US$45.50. On Syfe you can trade CUE with $0 commission and add it to your watchlist.
| Previous close | US$37.84 |
|---|---|
| Market cap | US$174.2M |
| 52-week range | US$4.97 – US$45.50 |
| Volume | 381.53K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Cue Biopharma, Inc.
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in advancing a portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its pipeline includes CUE-221, a novel anti-IgE antibody with a dual mechanism of action, and CUE-401, designed to regulate inflammation and drive Treg-mediated tolerance. The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.
Year: 2018
Cue Biopharma Names James Ahlers CFO Following FDA Filing for CUE-221 in Food Allergy
Aug 3, 1:32 PM · MT Newswires
Top Midday Gainers
Jul 10, 6:00 PM · MT Newswires
Cue Biopharma Announces $50 Million Private Placement
Jul 10, 7:52 AM · MT Newswires
Cue Biopharma Files for Shares Sale by Shareholder
Jun 18, 9:41 PM · MT Newswires
Cue Biopharma, Inc. (CUE) stock is trading at US$37.05, -2.09% from the previous close of US$37.84.
The market cap for Cue Biopharma, Inc. (CUE) stock is approximately US$174.2M.
The 52-week high for Cue Biopharma, Inc. (CUE) stock is US$45.50.
The 52-week low for Cue Biopharma, Inc. (CUE) stock is US$4.97.
Cue Biopharma, Inc. (CUE) does not currently pay a dividend.
Stay on top of CUE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
